Head-To-Head Contrast: Takeda Pharmaceutical (NYSE:TAK) and Aadi Bioscience (NASDAQ:AADI)
Aadi Bioscience (NASDAQ:AADI – Get Free Report) and Takeda Pharmaceutical (NYSE:TAK – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation and earnings. Risk and Volatility Aadi Bioscience has a beta […]
More Stories
Traders Purchase Large Volume of Call Options on Kirkland’s (NASDAQ:KIRK)
Kirkland’s, Inc. (NASDAQ:KIRK – Get Free Report) was the target of some unusual options trading activity on Wednesday. Traders purchased...
Chicago Rivet & Machine (NYSEAMERICAN:CVR) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Chicago Rivet & Machine (NYSEAMERICAN:CVR – Free Report) in a research report sent to...
Melrose Industries’ (MRO) Overweight Rating Reiterated at JPMorgan Chase & Co.
JPMorgan Chase & Co. restated their overweight rating on shares of Melrose Industries (LON:MRO – Free Report) in a research...
Canaccord Genuity Group Has Lowered Expectations for Aurrigo International (LON:AURR) Stock Price
Aurrigo International (LON:AURR – Free Report) had its price objective decreased by Canaccord Genuity Group from GBX 165 ($2.03) to...
BJ’s Restaurants (NASDAQ:BJRI) Cut to Market Perform at Oppenheimer
Oppenheimer downgraded shares of BJ’s Restaurants (NASDAQ:BJRI – Free Report) from an outperform rating to a market perform rating in...
HC Wainwright Reiterates “Buy” Rating for Arcturus Therapeutics (NASDAQ:ARCT)
HC Wainwright reissued their buy rating on shares of Arcturus Therapeutics (NASDAQ:ARCT – Free Report) in a research note published...